Ghent, Belgium, 15 January 2025 – ONTOFORCE, a leader in semantic technology for life sciences, headquartered in Ghent, Belgium, and Rancho Biosciences, the leading data science services company headquartered in San Diego, California, have announced a joint collaboration. This partnership aims to transform high quality data-driven research and drug development, providing scientists with unparalleled insights that drive discovery and innovation in the life sciences.
As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.
A world where we can 3D bioprint organs on demand is creeping ever closer to clinical reality, thanks to Belgian efforts to standardize the biomaterials necessary. Achieving this will have profound consequences for organ transplants, disease modeling, tissue engineering, personalized medicine, and drug discovery. But bioprinting success depends on multidisciplinary collaborations between material scientists, hardware manufacturers, clinicians, and other partners. Recently, these collaborations have reached the stratosphere, with a project to study cardiovascular aging with a heart-on-a-chip… in space!
Precision oncology, which tailors cancer treatments to an individual’s specific biological characteristics, has advanced significantly in recent years. Doctors are now using more targeted therapies that focus on specific cues or biomarkers in tissues, making treatments more personalized. Nevertheless, cancer is still a tough disease to fight, and many treatments do not consistently eliminate tumors. This is where the power of multiplex imaging comes in.
In a hospital, numerous single-use masks, gloves, syringes, and more are thrown away every day to safeguard patients. However, this linear supply chain leaves a large footprint and can have negative effects on our environment and public health. It seems that the road to achieving sustainable healthcare is not straightforward, but circular.
Luxembourg may be one of the smallest nations in the world, at just over 2,500 square kilometers and around 670,000 inhabitants, but it packs a punch in the global life sciences ecosystem. With world-class research institutes, startup accelerators, and the country’s growing digital prowess, Luxembourg is attracting global talent and putting digital healthtech solutions front and center.
So, how did the Grand Duchy establish and grow its thriving research and startup landscape, and what is the vision for the future?
Ghent, Belgium, 15 January 2025 – ONTOFORCE, a leader in semantic technology for life sciences, headquartered in Ghent, Belgium, and Rancho Biosciences, the leading data science services company headquartered in San Diego, California, have announced a joint collaboration. This partnership aims to transform high quality data-driven research and drug development, providing scientists with unparalleled insights that drive discovery and innovation in the life sciences.
As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.
A world where we can 3D bioprint organs on demand is creeping ever closer to clinical reality, thanks to Belgian efforts to standardize the biomaterials necessary. Achieving this will have profound consequences for organ transplants, disease modeling, tissue engineering, personalized medicine, and drug discovery. But bioprinting success depends on multidisciplinary collaborations between material scientists, hardware manufacturers, clinicians, and other partners. Recently, these collaborations have reached the stratosphere, with a project to study cardiovascular aging with a heart-on-a-chip… in space!
Precision oncology, which tailors cancer treatments to an individual’s specific biological characteristics, has advanced significantly in recent years. Doctors are now using more targeted therapies that focus on specific cues or biomarkers in tissues, making treatments more personalized. Nevertheless, cancer is still a tough disease to fight, and many treatments do not consistently eliminate tumors. This is where the power of multiplex imaging comes in.
In a hospital, numerous single-use masks, gloves, syringes, and more are thrown away every day to safeguard patients. However, this linear supply chain leaves a large footprint and can have negative effects on our environment and public health. It seems that the road to achieving sustainable healthcare is not straightforward, but circular.
Luxembourg may be one of the smallest nations in the world, at just over 2,500 square kilometers and around 670,000 inhabitants, but it packs a punch in the global life sciences ecosystem. With world-class research institutes, startup accelerators, and the country’s growing digital prowess, Luxembourg is attracting global talent and putting digital healthtech solutions front and center.
So, how did the Grand Duchy establish and grow its thriving research and startup landscape, and what is the vision for the future?